Related Experiment Video
Updated: Feb 14, 2026

Identification of Fatty Acids in Bacillus cereus
Published on: December 5, 2016
Bacillus cereus pneumonia in an immunocompetent patient: a case report
Yuichiro Shimoyama1, Osamu Umegaki1, Yukimasa Ooi2
11Department of Anesthesiology, Osaka Medical College, Intensive Care Unit, Osaka Medical College Hospital, 2-7 Daigaku-machi, Takatsuki, Osaka 569-8686 Japan.
Background:
Bacillus cereus (B. cereus) rarely causes lower respiratory tract infections, although most reported cases of B. cereus pneumonia are fatal despite intensive antibiotic therapy. We present a case of B. cereus pneumonia in an immunocompetent patient.
Case Presentation:
An 81-year-old woman was transferred from a district general hospital to our hospital for treatment of congestive heart failure. The patient presented with a nonproductive cough, dyspnea, edema in both lower extremities, orthopnea, fever, and occult blood in the stool. A chest radiograph indicated bilateral pleural effusion and pulmonary congestion. After diuretic therapy and chest drainage, bilateral pleural effusion and pulmonary congestion improved. On day 2, she experienced severe respiratory distress. B. cereus was isolated from two blood sample cultures. On day 4, her condition had progressed to severe respiratory distress (PaO2/FiO2 ratio = 108). A chest radiograph and computed tomography indicated extensive bilateral infiltrates. She was transferred to the intensive care unit and was intubated. B. cereus was also isolated from five blood sample cultures at that time. After isolating B. cereus, we switched antibiotics to a combination of imipenem and levofloxacin, which were effective. She had no history of immunodeficiency, surgery, ill close contacts, risk factors for HIV or tuberculosis, recent central venous catheter insertion, or anthrax vaccination. She improved and was discharged from the intensive care unit after several days.
Conclusion:
This is a rare case of B. cereus pneumonia in an immunocompetent patient, who subsequently recovered. Bacillus should be considered as a potential pathogen when immunocompetent patients develop severe pneumonia.
Insights
Bacillus cereus pneumonia is rare in immunocompetent individuals but can be severe. This case highlights that Bacillus cereus should be considered in severe pneumonia, even without immune compromise.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Pulmonology
Background:
- Bacillus cereus (B. cereus) rarely causes lower respiratory tract infections.
- Most reported cases of B. cereus pneumonia are fatal despite intensive antibiotic therapy.
- This study presents a rare case of B. cereus pneumonia in an immunocompetent patient.
Purpose of the Study:
- To report a rare case of severe Bacillus cereus pneumonia in an immunocompetent patient.
- To emphasize the importance of considering Bacillus cereus as a potential pathogen in severe pneumonia cases.
- To highlight the successful treatment outcome in a previously immunocompromised patient.
Main Methods:
- A case study of an 81-year-old female patient with congestive heart failure who developed severe pneumonia.
- Diagnostic procedures included chest radiography, computed tomography, and blood cultures.
- Treatment involved a switch to imipenem and levofloxacin antibiotics.
Main Results:
- The patient presented with symptoms of severe respiratory distress, bilateral infiltrates, and positive blood cultures for B. cereus.
- Despite initial intensive care, the patient's condition progressed, requiring intubation.
- The patient showed improvement and was discharged after antibiotic treatment with imipenem and levofloxacin.
Conclusions:
- Bacillus cereus pneumonia is an uncommon but potentially fatal infection.
- Immunocompetent patients can develop severe B. cereus pneumonia.
- Prompt recognition and appropriate antibiotic therapy are crucial for successful outcomes in B. cereus pneumonia.
More Related Videos
08:34Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Data Reporting and Recording
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Types of Reports I: Hands-off Report
Following are the key components and categories of hand-off reports:
Purpose and Process: